AzTrials
AzTrials

Postoperative ComplicationsNCT07314762

Elderly Patients Undergoing Surgery During Perioperative Period

An observational study of Postoperative Complications and Elderly, run by Second Affiliated Hospital of Wenzhou Medical University at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The elderly patients have poorer overall conditions and have lower tolerance to trauma, anesthesia, and surgery. Therefore, the incidence of postoperative complications is relatively higher. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
How many people
1,200 participants
Where
1 siteChina
Study dates
30 Dec 2023to 30 Dec 2030
How long will I take part?
1 Year
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: Surgical patients aged 65 or above or non-surgical subjects aged 65 or above

Who may be able to join

  • 1) Surgical patients aged 65 or above or non-surgical subjects aged 65 or above. 2) Agree to participate in this study and sign the informed consent form.

Who cannot join

  • 1)Refused to participate in the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site, 1 recruiting
  • The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, 325000

    Ting Li MD.PhD, 0577-88002888, liting1021@aliyun.com

    Recruiting

Other trials in China

About this study

Official title: Elderly Patients Undergoing Surgery During Perioperative Period: a Prospective Cohort Study

The elderly patients have poorer overall conditions and have lower tolerance to trauma, anesthesia, and surgery. Therefore, the incidence of postoperative complications is relatively higher. In non-cardiac surgeries, approximately 20% of elderly patients experience postoperative complications, and the incidence of postoperative delirium (POD) is 23.8%. This may lead to prolonged hospital stays, increased hospital costs, and affect prognosis and even mortality. The investigators plan to conduct a prospective cohort study by systematically collecting biological samples and clinical information of elderly patients during the perioperative period to explore the possible risk factors and pathogenesis of postoperative delirium and postoperative complications in elderly surgical patients, and to construct a risk prediction model for postoperative complications.

Keywords
postoperative delirium, elderly, Cohort study
Medical subject headings
Postoperative Complications, Emergence Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07314762
Study groupRoleWhat they receive
Surgical patients aged 65 years or olderFor the surgical group patients, questionnaires and scales measuring cognitive function, sleep quality, and quality of life were collected preoperatively, at 1-7 days post-operation, 30 days post-operation, and 1 year post-operation. During the operation, blood, cerebrospinal fluid, and other biological samples from the patients were also collected.
non-surgical subjects aged 65 years or olderFor the non-surgical group patients, patients' basic information was collected, along with cognitive scales, sleep scales, and quality of life questionnaires.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of postoperative delirium (POD) within 7 days after surgery

    POD is diagnosed daily using the Three-Minute Diagnostic Confusion Assessment Method (3D-CAM).

    Measured: Preoperative, during the first 7 postoperative days

Secondary outcomes (14)
  1. The types of postoperative delirium

    The type of delirium is assessed using the Richmond Agitation-Sedation Scale (RASS). The Richmond Agitation-Sedation Scale (RASS) is a 10-point scale ranging from -5 (unarousable) to +4 (combative). A score of +4 represents a combative state where the patient is violent and poses immediate danger, while a score of -5 indicates no response to any stimulus. Based on the RASS score, delirium can be categorized into three motoric subtypes: Hyperactive delirium: RASS scores consistently between +1 and +4. Hypoactive delirium: RASS scores consistently between 0 and -3. Mixed-type delirium: RASS scores that fluctuate between positive and negative values over the observation period.

    Measured: Preoperative, during the first 7 postoperative days

  2. The severity of postoperative delirium

    The severity of postoperative delirium will be assessed using the Confusion Assessment Method-Severity scale (CAM-S).

    Measured: Preoperative, during the first 7 postoperative days

  3. The duration of postoperative delirium

    Duration is defined as the number of days from the onset of delirium symptoms to symptom resolution or hospital discharge, whichever occurs first.

    Measured: Preoperative, during the first 7 postoperative days

  4. Postoperative neurocognitive dysfunction

    Neurocognitive decline is assessed by comparing baseline to postoperative scores on: Mini-Mental State Examination (MMSE, 0-30, higher=better function), Montreal Cognitive Assessment (MoCA, 0-30, higher=better function); and five neuropsychological tests-Clock Drawing Test, (DST, 0-16, higher=better attention), Trail Making Test Parts A and B (TMT-A/B, seconds, lower=better), Boston Naming Test (BNT, 0-30, higher=better naming), Auditory Verbal Learning Test - Huashan version (AVLT-H delayed recall, 0-10, higher=better memory), and Clock Drawing Test (CDT, 0-10, higher=better visuospatial/executive function). Patient/caregiver reports are also collected.

    Measured: preoperative baseline, within 7 days postoperatively, and at 1, 6, and 12 months postoperatively.

  5. Acute pain

    Using Visual Analogue Scale (VAS), 0-100, 0 means no pain, 100 means severe pain

    Measured: Preoperative and 3 days postoperative.

  6. Hospital Anxiety and Depression Scale (HADS) score

    The Hospital Anxiety and Depression Scale (HADS) is used for assessment, with each subscale (anxiety or depression) scored from 0-21: "0-7: Non-case", "8-10: Doubtful case", "11-21: Definite case". Higher scores clearly indicate worse outcomes, i.e., more severe anxiety or depression symptoms.

    Measured: preoperative, 5 days, 1 month, 6 months, and 1 year postoperative.

  7. Activity of Daily Living

    The Activities of Daily Living (ADL) are typically assessed using the Barthel Index. 0-100. A higher score indicates stronger independence: a score of 100 represents complete independence; a score of 61-99 suggests mild functional impairment with basic self-care ability; and a score of ≤40 indicates severe functional impairment, with significant or complete reliance on others for daily living.

    Measured: preoperative, 5 days, 1 month, 6 months, and 1 year postoperative.

  8. Sleep quality

    Sleep quality is assessed using the Pittsburgh Sleep Quality Index (PSQI). The total score ranges from 0 to 21 points. A score greater than 7 (>7) is typically considered the clinical cutoff for poor sleep quality. A higher score indicates poorer sleep quality.

    Measured: preoperative, 5 days, 1 month, 6 months, and 1 year postoperative.

  9. The FRAIL Scale

    The FRAIL (Fatigue, Resistance, Ambulation, Illnesses, and Loss of Weight) Scale ranges from 0 to 5. A score of 0 indicates robust/non-frail status, scores of 1-2 indicate pre-frail status, and scores of 3-5 indicate frail status.

    Measured: preoperative, 5 days, 1 month, 6 months, and 1 year postoperative.

  10. Quality of Life Score

    using EQ-5D(Score of EuroQol Five Dimensions Questionnaire (EQ-5D)) to measure quality of life

    Measured: preoperative, 1 month, 6 months, and 1 year postoperative.

  11. Mortality

    In-hospital mortality; 30-day postoperative mortality; 1-year postoperative mortality

    Measured: During hospitalization, 1 month, 6 months, and 1 year postoperative.

  12. Length of hospitalization

    Length of hospital stay are measured from the anesthesia starting day to the discharge day

    Measured: till the day of discharge from hospital, an average of 7 days

  13. Days at home up to 30 days after surgery (DAH30)

    Measured: up to 30 days after surgery

  14. Economic indicators

    Hospitalization fees; -Preoperative fees; -Anesthesia fees; -Surgery fees; -Post-operative fees; -Post-discharge medical expenses.

    Measured: during the entire trial, an average of 1 year.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jan 2026
  2. Study start30 Dec 2023
  3. Primary completion30 Dec 2030 (estimated)
  4. Study completion30 Dec 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,200 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT07314762
Sponsor's protocol ID
SAHoWMU-CR2025-03-231
Status last verified
Jan 2026
First submitted
11 Dec 2025
Last updated
1 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Study protocol and statistical analysis plan.

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Complications and Elderly, run by Second Affiliated Hospital of Wenzhou Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ting Li MD. PhD (+86-135-8787-6896, liting1021@aliyun.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of postoperative delirium (POD) within 7 days after surgery (time frame: Preoperative, during the first 7 postoperative days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT07314762 | AzTrials